88 related articles for article (PubMed ID: 10907083)
21. Screening for BRCA2 mutations in 81 Dutch breast-ovarian cancer families.
Peelen T; van Vliet M; Bosch A; Bignell G; Vasen HF; Klijn JG; Meijers-Heijboer H; Stratton M; van Ommen GJ; Cornelisse CJ; Devilee P
Br J Cancer; 2000 Jan; 82(1):151-6. PubMed ID: 10638982
[TBL] [Abstract][Full Text] [Related]
22. Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations.
Wagner T; Stoppa-Lyonnet D; Fleischmann E; Muhr D; Pagès S; Sandberg T; Caux V; Moeslinger R; Langbauer G; Borg A; Oefner P
Genomics; 1999 Dec; 62(3):369-76. PubMed ID: 10644434
[TBL] [Abstract][Full Text] [Related]
23. Optimization of a simple and rapid single-strand conformation analysis for detection of mutations in the PROS1 gene: identification of seven novel mutations and three novel, apparently neutral, variants.
Espinosa-Parrilla Y; Morell M; Borrell M; Souto JC; Fontcuberta J; Estivill X; Sala N
Hum Mutat; 2000; 15(5):463-73. PubMed ID: 10790208
[TBL] [Abstract][Full Text] [Related]
24. Mutational analysis of the BRCA1 tumor suppressor gene in endometrial carcinoma.
Liu FS; Ho ES; Shih RT; Shih A
Gynecol Oncol; 1997 Sep; 66(3):449-53. PubMed ID: 9299260
[TBL] [Abstract][Full Text] [Related]
25. Identification of specific BRCA1 and BRCA2 variants by DHPLC.
Gross E; Arnold N; Pfeifer K; Bandick K; Kiechle M
Hum Mutat; 2000 Oct; 16(4):345-53. PubMed ID: 11013445
[TBL] [Abstract][Full Text] [Related]
26. Structural factors determining DNA length limitations in conformation-sensitive mutation detection methods.
Kozlowski P; Krzyzosiak WJ
Electrophoresis; 2005 Jan; 26(1):71-81. PubMed ID: 15624145
[TBL] [Abstract][Full Text] [Related]
27. Genetic analysis of the insulin receptor gene in Chinese patients with extreme insulin resistance.
Lee WJ; Sheu WH; Shu SG; Yao YE
Zhonghua Yi Xue Za Zhi (Taipei); 1998 Nov; 61(11):636-42. PubMed ID: 9872020
[TBL] [Abstract][Full Text] [Related]
28. [Genetic alterations and DNA-based diagnosis in breast cancer].
Matsumoto S; Emi M; Kasumi F; Nakamura Y
Nihon Geka Gakkai Zasshi; 1996 May; 97(5):375-80. PubMed ID: 8709940
[TBL] [Abstract][Full Text] [Related]
29. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
[TBL] [Abstract][Full Text] [Related]
30. Optimization of PCR and electrophoresis conditions enhances mutation analysis of the BRCA1 gene.
Lallas TA; Buller RE
Mol Genet Metab; 1998 Jul; 64(3):173-6. PubMed ID: 9719625
[TBL] [Abstract][Full Text] [Related]
31. The detection of mitochondrial DNA mutations using single stranded conformation polymorphism (SSCP) analysis and heteroduplex analysis.
Thomas AW; Morgan R; Sweeney M; Rees A; Alcolado J
Hum Genet; 1994 Dec; 94(6):621-3. PubMed ID: 7989037
[TBL] [Abstract][Full Text] [Related]
32. BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer.
Seo JH; Cho DY; Ahn SH; Yoon KS; Kang CS; Cho HM; Lee HS; Choe JJ; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS; Son GS; Lee JB; Koo BH
Hum Mutat; 2004 Oct; 24(4):350. PubMed ID: 15365993
[TBL] [Abstract][Full Text] [Related]
33. BRCA1 and BRCA2 mutations in central and southern Italian patients.
Ottini L; D'Amico C; Noviello C; Lauro S; Lalle M; Fornarini G; Colantuoni OA; Pizzi C; Cortesi E; Carlini S; Guadagni F; Bianco AR; Frati L; Contegiacomo A; Mariani-Costantini R
Breast Cancer Res; 2000; 2(4):307-10. PubMed ID: 11056688
[TBL] [Abstract][Full Text] [Related]
34. Mutation screening of the BRCA1 gene in sporadic breast cancer in southern Chinese populations.
Haitian Z; Yunfei L; Jian Z; Jian L; Qinghua L; Fuqiang W
Breast; 2008 Dec; 17(6):563-7. PubMed ID: 18835712
[TBL] [Abstract][Full Text] [Related]
35. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
36. BRCA2 germline mutations in male breast cancer cases and breast cancer families.
Couch FJ; Farid LM; DeShano ML; Tavtigian SV; Calzone K; Campeau L; Peng Y; Bogden B; Chen Q; Neuhausen S; Shattuck-Eidens D; Godwin AK; Daly M; Radford DM; Sedlacek S; Rommens J; Simard J; Garber J; Merajver S; Weber BL
Nat Genet; 1996 May; 13(1):123-5. PubMed ID: 8673091
[TBL] [Abstract][Full Text] [Related]
37. Optimum sample medium for single-nucleotide polymorphism and mutation detection by capillary electrophoresis.
Kozlowski P; Krzyzosiak WJ
Electrophoresis; 2004 Apr; 25(7-8):990-8. PubMed ID: 15095439
[TBL] [Abstract][Full Text] [Related]
38. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families.
Cierniková S; Tomka M; Kovác M; Stevurková V; Zajac V
Neoplasma; 2006; 53(2):97-102. PubMed ID: 16575464
[TBL] [Abstract][Full Text] [Related]
39. Pitfalls and caveats in BRCA sequencing.
Bellosillo B; Tusquets I
Ultrastruct Pathol; 2006; 30(3):229-35. PubMed ID: 16825125
[TBL] [Abstract][Full Text] [Related]
40. Detection of mutations and polymorphisms in the p53 tumor suppressor gene by single-strand conformation polymorphism analysis.
Kutach LS; Bolshakov S; Ananthaswamy HN
Electrophoresis; 1999 Jun; 20(6):1204-10. PubMed ID: 10380760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
